MTIM
BIOR

Marathon Trading Investment Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Marathon Trading Investment Management’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-52
Closed -$27K – 391
2021
Q4 		$27K Buy
+52
New +$37.3K ﹤0.01% 286

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marathon Trading Investment Management's BIOR Position: Q1 2022 in Review

Marathon Trading Investment Management sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2022, closing a stake of 52 shares — an estimated $27K sold.

Marathon Trading Investment Management first reported a position in BIOR in Q4 2021 and held it in 1 quarter. The position peaked at $27K in Q4 2021. 51 funds tracked by Wall St. Rank hold BIOR as of Q1 2022.

  • Marathon Trading Investment Management reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Marathon Trading Investment Management sold 52 Biora Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $27K.
  • Marathon Trading Investment Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Marathon Trading Investment Management's Biora Therapeutics, Inc. Common Stock position peaked at $27K in Q4 2021.
  • 51 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Marathon Trading Investment Management's 13F filing for Q1 2022, filed 16 May 2022.